Case Report
Accepted on 08 Apr 2025
Complete Remission of a High-risk, Locally Advanced Cervical Cancer with Para-aortic Lymph Node Metastases Treated with First-line Tislelizumab plus Bevacizumab Combined with Chemotherapy Followed by Radiotherapy with Maintenance Therapy: a Case Report
in Cancer Immunity and Immunotherapy